NEUROBIOLGL TECH INC NTII (NASDAQ) $ 0.49 Change: +0.03 +6.12% | Volume: 319,418

NEUROBIO TECH - Fundamental Profile

Company Information

Ticker Symbol: NTII
Exchange: NASD
Contact Info: 2000 Powell Street Emeryville CA 94608 510 595-6000
CEO/President: Paul E. Frieman
Industry: Medical - Drugs / Standard Industry Code: 2836
Description: Neurobiological Tech. is an emerging drug development company focused on the clinical evaluation and regulatory approval of neuroscience drugs. The company\'s strategy is to in-license and develop early-stage drug candidates that target major medical needs and which can be rapidly commercialized.

Share Information

Shares Outstanding: 26,910 (000) Market Value: 12,650 ($000)
Percentage of Inst.Shareholders: 68.84% Number of Inst.Shareholders: 0.34%
Last Quarter Sales: 3.51 ($Mil.) Last Quarter Net Income: -3.45 ($Mil.)
Last Quarter EPS: -0.13 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: -0.87
Most Recent Split: 1-7 on 09/17/07 Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement